Title : A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies.

Pub. Date : 2007 Jul

PMID : 17559747






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Initial clinical trial experience with the new oral DPP-4 inhibitors such as sitagliptin and vildagliptin suggests that these agents are weight-neutral, while providing improved glycaemic control when added to metformin. Metformin dipeptidyl peptidase 4 Homo sapiens
2 Initial clinical trial experience with oral DPP-4 inhibitors such as sitagliptin and vildagliptin suggest that these agents may represent an important oral treatment option for weight-neutral, glycaemic control when added to metformin. Metformin dipeptidyl peptidase 4 Homo sapiens